Pulmovant, Inc.
Clinical trials sponsored by Pulmovant, Inc., explained in plain language.
-
New inhaled drug tested for deadly combo of lung scarring and high pressure
Disease control OngoingThis study is testing whether an inhaled drug called mosliciguat is safe and effective for people who have high blood pressure in their lungs (pulmonary hypertension) caused by underlying lung scarring (interstitial lung disease). About 135 participants will be randomly assigned …
Phase: PHASE2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated Mar 02, 2026 15:25 UTC
-
Scientists track experimental drug through the body
Knowledge-focused OngoingThis early-stage study aims to understand how the body absorbs, breaks down, and eliminates the experimental drug Mosliciguat. It will involve 8 healthy adult male volunteers who will receive the drug in different forms. The main goal is to measure how much of the drug gets into …
Phase: PHASE1 • Sponsor: Pulmovant, Inc. • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC